Director Access Strategy - Recensione dipendente - Director Access Strategy presso Genentech

4,0
24 feb 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Smart people , great mission and great products

Svantaggi

too political, overly complex and lack of pragmatiscm

avatar
Risposta di Genentech
3mo
Thank you for your feedback! We’re glad to hear you’re inspired by our mission, our products, and the talented people you work with every day. We recognize that being a large and complex company sometimes results in lengthier processes. And, as an FDA regulated company, there are myriad considerations that often impact timelines. With this in mind, we continue to work on streamlining our processes, incorporating more agility into the way we work whenever possible. Thank you for your contributions during your time here and hope to see you again at Genentech someday.

Esplora altre recensioni su Genentech

5,0
6 giu 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Great salary and team! The interview process was smooth and effective.

Svantaggi

To be determined, but so far many alignment meetings. Some folks have frustuations around the re-org and strategy changes.

2,0
19 giu 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

The work is meaningful and overall the company vision aligns with my goals

Svantaggi

QA management has become inept. None of the leadership (aside from maybe one or two) truly understand the nuances of our site and jobs. They refuse to pay you more due to "budget" reasons but won't provide much information, they claim to be transparent but will make decisions behind your back and not communicate them, even if they impact you and/or your job. Leadership doesn't listen to feedback and gets defensive if you even try to give any. It honestly has become a game of politics only in QA and that's not really building any real quality culture.

Vedi recensioni per: Utile|Valutazione|Data|Tutto